Company news
LivaNova PLC news in 2022
LivaNova PLC's news releases, calls and decks from 2022, newest first.
LivaNova Announces Receipt of Close-Out of Warning Letter from U.S. Food and Drug Administration
December 12, 2022
LivaNova to Present Scientific Data at American Epilepsy Society 2022 Annual Meeting
November 29, 2022
LivaNova Receives 510(k) Clearance for ECMO from FDA for LifeSPARC, the Next-generation Advanced Circulatory Support System
November 16, 2022
LivaNova to Present at the Stifel, Wolfe and Piper Sandler Healthcare Conferences
November 7, 2022
LivaNova Reports Third-Quarter 2022 Results
November 1, 2022
LivaNova to Announce Third-Quarter 2022 Results
September 20, 2022
LivaNova Board Appoints Brooke Story as a New Director
September 14, 2022
LivaNova Reports Second-Quarter 2022 Results
August 2, 2022
LivaNova to Announce Second-Quarter 2022 Results
June 21, 2022
LivaNova Elects Peter Wilver to Board of Directors
June 13, 2022
LivaNova to Present at the Goldman Sachs Global Healthcare Conference
May 24, 2022
LivaNova Reports First-Quarter 2022 Results
May 3, 2022
LivaNova Initiates Targeted Commercial Launch of the Essenz Patient Monitor for Cardiopulmonary Bypass Procedures
April 7, 2022
LivaNova to Announce First-Quarter 2022 Results
March 23, 2022
LivaNova Announces 250th Unipolar Depression Patient Implanted in RECOVER Clinical Study
March 13, 2022
LivaNova Announces First Patient Implanted in OSPREY Clinical Study for Patients Coping with Obstructive Sleep Apnea
February 23, 2022
LivaNova Reports Fourth-Quarter and Full-Year 2021 Results
February 22, 2022
LivaNova to Announce Fourth-Quarter and Full-Year 2021 Results
January 11, 2022
Calls in 2022
Decks in 2022
- Q3 2022 Earnings Presentation
Earnings · 28 slides · Nov 2, 2022